THEREGEN INC has a total of 21 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are NEOSTEM INC, NEUROTROPHINCELL PTY LTD and NAUGHTON GAIL K.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Japan | 2 | |
#5 | Hong Kong | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Naughton Gail K | 19 |
#2 | Williams Stuart K | 11 |
#3 | Kellar Robert S | 11 |
#4 | Siani-Rose Michael | 9 |
#5 | Zeltinger Joan | 3 |
#6 | Mansbridge Jonathan Noel | 3 |
#7 | Edison Linette J | 2 |
#8 | Ratcliffe Anthony | 2 |
#9 | Pinney Robert E | 2 |
#10 | Pinney Emmett | 2 |
Publication | Filing date | Title |
---|---|---|
AU2011235932A1 | Use of cultured three-dimensional tissue for treating congestive heart failure | |
US2009186001A1 | Methods for Treating Ischemic Tissue | |
AU2005306270A1 | Use of cutured three-dimensional tissue for treating congestive heart failure | |
AU2005279771A1 | Cultured three dimensional tissues and uses thereof | |
EP1782849A2 | Three-dimensional stromal tissue |